TXG: 10x Genomics, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 3,286.61
Enterprise Value ($M) 2,927.33
Book Value ($M) 741.04
Book Value / Share 6.22
Price / Book 4.44
NCAV ($M) 371.92
NCAV / Share 3.12
Price / NCAV 8.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.25
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 4.11
Current Ratio 4.69

Balance Sheet (mrq) ($M)
Current Assets 596.02
Assets 965.14
Liabilities 224.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 618.73
Operating Income -194.95
Net Income -255.10
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.20
Cash from Investing 133.49
Cash from Financing 13.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 8.65 7.02
02-09 13G/A Fmr Llc 16.25 35.90
01-31 13G/A BlackRock Inc. 5.50 7.25
01-29 13G/A Baillie Gifford & Co 7.60 -7.93
12-08 13G/A Morgan Stanley 3.50 -29.36

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 188,576 639,100 29.51
2024-04-23 315,038 721,194 43.68
2024-04-22 293,155 744,119 39.40
2024-04-19 390,792 827,675 47.22

(click for more detail)

Similar Companies
SEER – Seer, Inc. TER – Teradyne, Inc.
TRMB – Trimble Inc.


Financial data and stock pages provided by
Fintel.io